Home / Health / Rare Childhood Dementia Diagnosis: A Mother's Fight
Rare Childhood Dementia Diagnosis: A Mother's Fight
10 Jun
Summary
- Merrick was diagnosed with Sanfilippo syndrome, a rare genetic disorder causing childhood dementia.
- The diagnosis came after years of unanswered questions and a perceived regression in skills.
- A gene therapy, UX111, is in FDA approval, offering potential hope for children with the condition.
A mother shares her profound experience navigating her son Merrick's health, which initially led to diagnoses of autism and ADHD. She recounts Merrick's early brightness, followed by a concerning regression in skills around age five. The COVID-19 pandemic complicated matters, isolating the family and obscuring the cause of Merrick's decline.
Years of searching for answers culminated in June 2024 when Merrick, then 10 years old, was diagnosed with Sanfilippo syndrome. This rare genetic disorder is often described as childhood dementia, progressively impacting speech, mobility, and independence. The diagnosis came with immense emotional weight, especially given Merrick's age, making him too old for certain clinical trials.
Currently, there is no cure or approved treatment for Sanfilippo syndrome. However, hope exists with the gene therapy UX111, which is undergoing FDA review. Merrick might be eligible for this treatment if approved. In the interim, his family is implementing strategies to slow progression and advocates for increased awareness, funding, and earlier access to treatments.
The mother urges other parents to trust their instincts and advocate fiercely for their children's health. She emphasizes the importance of early diagnosis and timely treatment, sharing their story to ensure other families receive answers sooner and access life-changing therapies before it is too late.
